Table 2 Clinical trends after treatment

Mean ± SD

Median [Q1; Q3]

Mean ± SD

Median [Q1; Q3]

Mean ± SD

Median [Q1; Q3]

Mean ± SD

Median [Q1; Q3]

Period from NUx to ST (months)

1.2 ± 0.5

1.1 [ 0.9; 1.4]

4.8 ± 3.0

4.0 [ 2.6; 6.1]

< 0.001

1.2 ± 0.5

1.1 [ 0.9; 1.4]

4.8 ± 3.0

4.0 [ 2.6; 6.1]

< 0.001

Hospitalization duration at NUx (days)

13.2 ± 6.3

11.0 [10.0;15.0]

14.1 ± 8.6

12.0 [10.0;16.0]

0.323

12.7 ± 6.0

11.0 [ 9.0;15.0]

14.1 ± 8.6

12.0 [10.0;16.0]

0.148

3-months readmission rate after NUx (%)

0.063

0.502

- No

1451 (73.1%)

60 (63.8%)

129 (68.6%)

60 (63.8%)

- Yes

533 (26.9%)

34 (36.2%)

59 (31.4%)

34 (36.2%)

Transfusion at NUx (%)

< 0.001

< 0.001

- No

1206 (60.8%)

35 (37.2%)

122 (64.9%)

35 (37.2%)

- Yes

778 (39.2%)

59 (62.8%)

66 (35.1%)

59 (62.8%)

Volume of transfusion at NUx (packs)

3.3 ± 2.6

2.0 [ 2.0; 4.0]

3.2 ± 2.0

2.0 [ 2.0; 4.0]

0.872

3.6 ± 3.0

3.0 [ 2.0; 4.0]

3.2 ± 2.0

2.0 [ 2.0; 4.0]

0.678

G-CSF usage rate (%)

< 0.001

0.004

- No

1272 (64.1%)

79 (84.0%)

126 (67.0%)

79 (84.0%)

- Yes

712 (35.9%)

15 (16.0%)

62 (33.0%)

15 (16.0%)

The number of G-CSF usage, during ST

2.7 ± 3.0

2.0 [ 1.0; 3.0]

2.1 ± 1.9

1.0 [ 1.0; 2.5]

0.445

2.4 ± 2.0

2.0 [ 1.0; 3.0]

2.1 ± 1.9

1.0 [ 1.0; 2.5]

0.603

The number of G-CSF usage, during total period

2.8 ± 3.1

2.0 [ 1.0; 3.0]

2.3 ± 1.8

2.0 [ 1.0; 3.0]

2.6 ± 2.2

2.0 [ 1.0; 3.0]

2.3 ± 1.8

2.0 [ 1.0; 3.0]

0.558

The rate of G-CSF usage within 3-months (%)

0.182

0.147

- No

1659 (83.6%)

84 (89.4%)

154 (81.9%)

84 (89.4%)

- Yes

325 (16.4%)

10 (10.6%)

34 (18.1%)

10 (10.6%)

Dialysis after NUx

0.278

0.398

- No

1895 (95.5%)

87 (92.6%)

180 (95.7%)

87 (92.6%)

- Yes

89 (4.5%)

7 (7.4%)

8 (4.3%)

7 (7.4%)

Preoperative URS biopsy (%)

< 0.001

0.006

- No

1658 (83.6%)

65 (69.1%)

158 (84.0%)

65 (69.1%)

- Yes

326 (16.4%)

29 (30.9%)

30 (16.0%)

29 (30.9%)

Preoperative TUR-BT (%)

< 0.001

< 0.001

- No

1759 (88.7%)

64 (68.1%)

166 (88.3%)

64 (68.1%)

- Yes

225 (11.3%)

30 (31.9%)

22 (11.7%)

30 (31.9%)

TUR-BT after NUx (%)

0.866

1.000

- No

1472 (74.2%)

71 (75.5%)

141 (75.0%)

71 (75.5%)

- Yes

512 (25.8%)

23 (24.5%)

47 (25.0%)

23 (24.5%)

Period from NUx to TUR-BT (months)

17.4 ± 16.4

12.2 [ 8.4;21.0]

15.1 ± 16.8

10.0 [ 3.9;15.0]

0.523

15.6 ± 13.1

12.2 [ 7.8;21.6]

15.1 ± 16.8

10.0 [ 3.9;15.0]

0.910

The rate of radiotherapy (%)

0.860

0.497

- No

1750 (88.2%)

84 (89.4%)

174 (92.6%)

84 (89.4%)

- Yes

234 (11.8%)

10 (10.6%)

14 (7.4%)

10 (10.6%)